Search Results - "Khiri, Hacene"

Refine Results
  1. 1
  2. 2

    Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs by Ouzan, Denis, Pénaranda, Guillaume, Joly, Hélène, Khiri, Hacène, Pironti, Antonnella, Halfon, Philippe

    Published in Journal of clinical virology (01-12-2013)
    “…Abstract Background and objective The aim of this study was to prospectively evaluate whether the addition of peg-IFN to a stable NA regimen leads to loss of…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation by Halfon, Philippe, Berger, Pierre, Khiri, Hacene, Martineau, Agnès, Pénaranda, Guillaume, Merlin, Michèle, Faucher, Catherine

    Published in Journal of medical virology (01-03-2011)
    “…Preemptive therapy in hematopoietic cell transplantation is initiated by a diagnostic technique at first detection of cytomegalovirus (CMV). The aim of this…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    High Prevalence of Asymptomatic Sexually Transmitted Infections among Men Who Have Sex with Men by Philibert, Patrick, Khiri, Hacène, Pénaranda, Guillaume, Camus, Claire, Drogoul, Marie-Pierre, Halfon, Philippe

    Published in Journal of clinical medicine (12-12-2014)
    “…Men who have sex with men (MSM) are disproportionately affected by sexually transmitted infection. The aim of this cross-sectional study is to prospectively…”
    Get full text
    Journal Article
  11. 11

    Cytological and virological medium performance and stability assessment using the Cobas 4800 HPV test (Roche Diagnostics) used in France by Khiri, Hacène, Camus, Claire, Portugal, Mireille, Pénaranda, Guillaume, Boyer, Stéphane, Halfon, Philippe

    Published in Annales de biologie clinique (Paris) (01-03-2014)
    “…Analytical and stability performances of ten media were compared to PreservCyt medium using the Cobas 4800 HPV test: Easyfix (Labonord SAS, France), Qualicyt…”
    Get more information
    Journal Article
  12. 12

    Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: A cross-sectional study by Camus, Claire, Penaranda, Guillaume, Khiri, Hacène, Camiade, Sabine, Molet, Lucie, Lebsir, Melissa, Plauzolles, Anne, Chiche, Laurent, Blanc, Bernard, Quarello, Edwin, Halfon, Philippe

    Published in PloS one (18-11-2021)
    “…Screening for genital infection (GI) such as bacterial vaginosis (BV) and yeast infection, for sexually transmitted infection (STI), and for asymptomatic…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure by MOHAMED, Sofiane, PENARANDA, Guillaume, GONZALEZ, Dimitri, CAMUS, Claire, KHIRI, Hacène, BOULME, Ronan, SAYADA, Chalom, PHILIBERT, Patrick, OLIVE, Daniel, HALFON, Philippe

    Published in AIDS (London) (01-06-2014)
    “…Drug-resistance mutations are routinely detected using standard Sanger sequencing, which does not detect minor variants with a frequency below 20%. The impact…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Dried blood spot sampling for hepatitis B virus serology and molecular testing by Mohamed, Sofiane, Raimondo, Audrey, Pénaranda, Guillaume, Camus, Claire, Ouzan, Denis, Ravet, Sophie, Bourlière, Marc, Khiri, Hacène, Dukan, Patrick, Olive, Daniel, Halfon, Philippe

    Published in PloS one (16-04-2013)
    “…Dried blood spots (DBS) on filter paper have been successfully used to diagnose and monitor several infectious diseases. The aim was to investigate the…”
    Get full text
    Journal Article
  17. 17

    Real-Time PCR Assays for Hepatitis C Virus (HCV) RNA Quantitation Are Adequate for Clinical Management of Patients with Chronic HCV Infection by Halfon, Philippe, Bourlière, Marc, Pénaranda, Guillaume, Khiri, Hacène, Ouzan, Denis

    Published in Journal of Clinical Microbiology (01-07-2006)
    “…Because of the use of viral kinetics during polyethylene glycol (PEG)-interferon-ribavirin therapy and the development of specific new anti-hepatitis C virus…”
    Get full text
    Journal Article
  18. 18

    HHV8 and Kaposiʼs sarcoma: should we really give up protease inhibitors in all HIV-infected patients? by Philibert, Patrick, Chiche, Laurent, Caillères, Sylvie, Allemand, Julie, Rebaudet, Stanislas, Delord, Marion, Stavris, Chloé, Retornaz, Frédérique, Khiri, Hacène, Halfon, Philippe

    Published in AIDS (London) (24-09-2017)
    “…We describe the first case of a patient presenting Kaposiʼs sarcoma with human herpes virus 8 (HHV8) viremia after switching from a protease inhibitor to an…”
    Get full text
    Journal Article
  19. 19

    Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV-1 infected patients by Mohamed, Sofiane, Ravet, Sophie, Camus, Claire, Khiri, Hacène, Olive, Daniel, Halfon, Philippe

    Published in Journal of medical virology (01-03-2014)
    “…The objective of this study was to assess the analytical and clinical relevance of minority variants using a new pyrosequencing (PSQ) assay and to detect minor…”
    Get full text
    Journal Article
  20. 20

    Use of Phylogenetic Analysis of Hepatitis C Virus (HCV) Hypervariable Region 1 Sequences To Trace an Outbreak of HCV in an Autodialysis Unit by HALFON, Philippe, ROUBICEK, Christa, GEROLAMI, Victoria, QUENTIN, Yves, KHIRI, Hacene, PEPE, Gérad, BERLAND, Yvon

    Published in Journal of Clinical Microbiology (01-04-2002)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article